Cytomegalovirus pp65 antigen-guided preemptive therapy with ganciclovir in solid organ transplant recipients: A prospective, double-blind, placebo-controlled study

Transplantation

Volumn 72, Issue 7, 2001, Pages 1325-1327

  Koetz, Arne C ^a,b,c   Delbrück, Regine ^a,b,d   Furtwängler, Alexander ^a   Hufert, Frank T ^b   Neumann Haefelin, Dieter ^b   Kirste, Günter ^a   Meyer König, Ursula ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c Institute for Medical Microbiology   (Germany)

^d Labor Drs Deimann und Burgard   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS ANTIGEN; GANCICLOVIR; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ADULT; ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CYTOMEGALOVIRUS; INFECTION PREVENTION; INFECTION RISK; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL;

EID: 0035886360     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200110150-00025     Document Type: Article

References (10)

1. Control of cytomegalovirus-associated morbidity in renal transplant patients using intensive monitoring and either preemptive or deferred therapy
2. Cytomegalovirus prophylaxis in solid organ transplant recipients
3. Prophylaxis against CMV infection in transplant patients
4. Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients
5. Laboratory diagnosis of HCMV-related disease in renal transplant patients - pp65 antigen detection versus nested PCR
6. Definition of cytomegalovirus infection and disease
7. Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solidorgan transplants
8. Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation
9. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation
10. Cytomegalovirus pp65 antigenemia monitoring as a guide for preemptive therapy: A cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients